Sun Pharmaceutical Industries
BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01028 | Pharmaceuticals
 |
 |
Quarterly Results of Sun Pharmaceutical Industries |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Sep '08 | Dec '08 | Mar '09 | Jun '09 | Sep '09 | ||||||
|
||||||||||
| Sales Turnover | 929.37 | 862.93 | 1,398.44 | 476.75 | 664.13 | |||||
| Other Income | 30.23 | 3.85 | -228.91 | 14.66 | -62.72 | |||||
| Total Income | 959.60 | 866.78 | 1,169.53 | 491.41 | 601.41 | |||||
| Total Expenses | 664.39 | 623.33 | 771.99 | 379.95 | 399.57 | |||||
| Operating Profit | 264.98 | 239.60 | 626.45 | 96.80 | 264.56 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -5.35 | 5.35 | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 295.21 | 243.45 | 397.54 | 111.46 | 201.84 | |||||
| Interest | -29.66 | -32.98 | -53.32 | -32.13 | -30.87 | |||||
| PBDT | 324.87 | 271.08 | 456.21 | 143.59 | 232.71 | |||||
| Depreciation | 14.60 | 14.40 | 15.58 | 17.26 | 16.62 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 310.27 | 256.68 | 440.63 | 126.33 | 216.09 | |||||
| Tax | 7.13 | -- | 15.94 | 4.82 | 13.03 | |||||
| Net Profit | 303.14 | 256.68 | 424.69 | 121.51 | 203.06 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 14.64 | 12.39 | 20.50 | 5.87 | 9.80 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 103.56 | 103.56 | 103.56 | 103.56 | 103.56 | |||||
| Reserves | -- | -- | 5,047.86 | -- | -- | |||||
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Sun Pharma connections | ||||||||||
| ||||||||||
